ABVC vs BIIB · rev $796.0K vs P/E 21, rev $9.89B
ABVC Biopharma Inc (ABVC) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
ABVC currently screens at market cap $35.9M. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the ABVC and BIIB stock pages for the full models.
Not investment advice.